Progress in biotechnology is continually leading to new types of data, and the data sets are rapidly increasing in volume, resolution and diversity. This promises unprecedented advances in our ...
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial We provide a set of ...
Deep-Learning–Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data We describe in detail a use case in pancancer transcriptomics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback